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Available online 29 January 2013Abstract Marked sequence variation in the mtDNA control region has been observed in human single CD34+ cells, which
persist in vivo and are present also in differentiated hematopoietic cells. In this study, we analyzed 5071 single CD34+ cells
from 49 individuals (including 31 maternally related members from four families and 18 unrelated donors) in order to
determine the mutation spectrum within the mtDNA control region in single cells, as related to aging and family genetic
background. Many highly mutated sites among family members were hypervariable sites in the mtDNA control region. Further,
CD34+ cells from members of the same family also shared several unique mtDNA variants, suggesting pedigree-specific
occurrence of these variants. Overall age-related accumulation of mtDNA mutations in CD34+ cells varied in different families,
suggesting a specific accumulation pattern, which might be modulated by family genetic background. Our current findings have
implications for the occurrence of mtDNA mutations in hematopoietic stem cells and progenitors.
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http://dx.doi.org/10.1016/j.scr.2013.01.006Mitochondria play a central role in energy metabolism, in
which mitochondrial oxidative phosphorylation is an extremely
efficient system to produce energy required for the body
(Wallace et al., 2010). Although reactive oxygen species
(ROS) are a natural byproduct during the normal oxidative
phosphorylation process, increased production of ROS and
decline of mitochondrial respiratory capacity is observed
during aging (Finkel and Holbrook, 2000; Vendelbo and Nair,
362 Y.-G. Yao et al.2011). Oxidation of cell components by ROS affects the
function of various tissues and organs with age (Finkel and
Holbrook, 2000; Vendelbo and Nair, 2011). Under the
mitochondrial theory of aging, aging is a vicious cycle
between elevated ROS andmitochondrial dysfunction, leading
to mtDNA damage and age-related cell death or senescence
(Harman, 1972; Nagley and Wei, 1998; Trifunovic, 2006).
This theory has been broadly supported by previous reports
of accumulation of mtDNA mutations with aging (Greaves
and Turnbull, 2009; Trifunovic, 2006), as well as molecular
genetic and evolutionary studies (Agarwal and Sohal, 1996;
Barja, 2004; Beckman and Ames, 1998; Finkel and Holbrook,
2000).
In our previous studies, we employed mtDNA sequence
analysis of single hematopoietic cells to assess aging
effects on the accumulation of mutations (Shin et al.,
2004; Yao et al., 2007c). In particular, we found that
human hematopoietic stem cells (HSCs) and progenitors,
as represented by CD34+ cell surface staining, showed
striking intercellular and intracellular mtDNA sequence
variations (Ogasawara et al., 2005; Yao et al., 2007b,
2007d). Some of these sequence variations in single CD34+
cells persisted in vivo over time (Yao et al., 2007b) and
were present in CD34+ cell progeny, circulating white
blood cells (Ogasawara et al., 2005). In transplanted
patients, CD34+ cells from the donor could be tracked by
their distinctive mtDNA mutations as patients became full
myeloid chimeras (Yao et al., 2007b). mtDNA mutation
analysis of murine HSCs and progenitors showed age-
related accumulation of mutations, dependent on the
nuclear genetic background (Yao et al., 2007c). However,
as we also reported (Yao et al., 2007b), a preliminary
analysis of human mtDNA variation in individual CD34+
cells from the healthy adults (aged from 25 to 65 years)
revealed no obvious correlation between the mtDNA
mutation number and the age of the individual, and the
mutation levels in CD34+ cells from the adult samples
could be seemingly classified into two groups defined by
6.5–12.8 haplotypes per 100 cells and 29.7–42.6 haplo-
types per 100 cells. These results are reminiscent of
potential modulation from the nuclear genetic background as
observed in mice (Yao et al., 2007c). In one intriguing finding,
based on comparison of CD34+ cells from the maternally
related donors and recipients, a very small portion of CD34+
cells shared certain nucleotide substitutions that appeared to
be exclusive to the family (Yao et al., 2007b). The nature of
these “family-specific” mutations in HSCs and progenitors
from siblings, perhaps transmitted with the mother's mito-
chondria, or occurring somatically in parallel, or otherwise
modulated by the nuclear genetic background, remained to be
validated and clarified.
In the current work, we have analyzed 5071 single CD34+
cells from 49 persons. Among them, 32 individuals were newly
collected from four families, in age ranging from 13 to
89 years, and three samples were cord blood. We had two
aims: (1) to examine the mutation spectra of the noncoding
mtDNA control region in single CD34+ cells from maternally
related individuals and to characterize the family-specific
occurrence of mtDNA mutations; (2) to discern an aging effect
on mutation accumulation in the mtDNA control region in
single CD34+ cells. With an enlarged sample size and members
from a family, we were able to obtain a comprehensivecharacterization of the mtDNA mutation spectrum, providing
some insight into age, family genetic background and mtDNA
mutations in human cells.
Materials and methods
Subjects
A total of 32 healthy individuals from four families were
recruited for this study (Table 1 and Fig. 1). For each
individual, peripheral blood (PB, 8–10 mL) was collected in a
heparinized tube and mononuclear cells (MNCs) were isolated
by Ficoll density gradient centrifugation after overnight
shipping and delivery. For donors in Family B living in Italy
(N=11), the same amount of PB was collected and processed
locally within 24 h of phlebotomy for MNC separation,
freezing, and storage; frozen MNCs were shipped to our
laboratory at Bethesda on dry ice and then transferred to
liquid nitrogen until they were subjected to single cell sorting.
A control group was composed of 18 unrelated individuals:
three cord blood (CB) samples and one member (C-2) from
Family C (this study); 14 healthy individuals reported in our
previous studies (Ogasawara et al., 2005; Yao et al., 2007b,
2007d). A total of 20 samples (1952 CD34+ cells) were obtained
from these 18 unrelated individuals as two of the 14 reported
healthy individuals were sampled twice at different time
points (Yao et al., 2007b). All donors gave informed consent,
and this study was approved by the institutional review board
of the National Heart, Lung, and Blood Institute.
Single CD34+ cell sorting and PCR amplification
Single CD34+ cells were isolated and analyzed using the same
procedure described in our previous studies (Ogasawara et
al., 2005; Yao et al., 2007b, 2007d). In brief, after thawing
and washing with phosphate buffered saline (PBS), cells
were suspended in 100 μL of PBS containing 0.5% bovine
serum albumin (BSA) and incubated with anti-CD34 phyco-
erythrin (PE)-conjugated monoclonal antibody (BD Biosci-
ence, San Jose, CA) for 30 min at 4 °C. Cells were then
washed, resuspended in 600 μL of PBS with 0.5% BSA, and
added 4 μL of 7-amino-actinomycin D (7-AAD). Cell sorting
was performed on the MoFlo Legacy high-performance cell
sorter (Dako-Cytomation, Ft Collins, CO), using 100 mW of
the 488 nm line of an argon laser (I-90, Coherent, Palo Alto,
CA) for excitation. Forward scatter was the triggering
parameter (Fig. S3). Single cell deposition was accomplished
using the CyClone Automated Cloner (Dako-Cytomation, Ft
Collins, CO) in a 0.5 single drop mode with gating, based on
forward scatter and fluorescence. Single CD34+ cells were
sorted into each well of an optical 96-well reaction plate
containing 50 μL of lysis buffer (10 mM Tris–HCl [pH 8.0],
50 mM KCl, 100 μg/mL Proteinase K, and 1% Triton X-100).
The plate was incubated at 56 °C for 30 min, followed by an
additional incubation at 96 °C for 8 min.
Two-step nested PCR was used to amplify the entire mtDNA
control region in single CD34+ cells, following the same PCR
condition as reported previously (Yao et al., 2007b, 2007d). In
brief, the first PCR was performed in a total volume of 30 μL,
which contains 400 μM of each dNTP, 1 unit of TaKaRa LA Taq™
(which has proof reading activity, with a relative error rate of
Table 1 The level of mtDNA sequence variation in single CD34+ cell populations from 49 healthy donors with different ages.
Sample Age Sex No.
of
cells
No. of
haplotypes
No. of nonaggregate
haplotypes by
nucleotide
substitutions
No. of cells
with
nonaggregate
sequences
No. of cells with
nonaggregate
sequences defined
by substitution
Reference
A-1 85 F 91 50 43 52 43 This study
A-2 55 M 92 35 28 40 28 This study
A-3 59 F 93 25 20 38 22 This study
A-4 35 M 93 13 8 36 10 This study
A-5 30 M 93 27 21 40 21 This study
A-6 25 F 95 12 5 32 14 This study
B-1 83 M 95 39 33 74 33 This study
B-2 81 M 94 42 36 73 36 This study
B-3 89 F 86 48 42 71 42 This study
B-4 79 F 96 35 29 74 29 This study
B-5 87 F 95 49 40 70 41 This study
B-6 60 F 95 47 38 73 41 This study
B-7 47 M 95 38 29 73 29 This study
B-8 51 M 94 35 28 64 29 This study
B-9 54 F 94 52 43 74 43 This study
B-10 57 F 93 37 30 70 30 This study
B-11 27 M 91 35 27 69 27 This study
B-12 21 M 185 76 70 160 90 This study
B-13 20 M 191 77 70 132 70 This study
B-14 13 M 96 54 43 85 43 This study
B-15 32 F 96 50 41 76 42 This study
B-16 28 F 96 31 23 71 23 This study
C-1 80 F 93 51 45 61 46 This study
C-2 79 M 94 45 37 65 37 This study
C-3 76 F 96 17 15 19 17 This study
C-4 46 F 96 48 43 56 44 This study
C-5 49 M 112 14 13 13 13 This study
C-6 46 F 95 8 5 7 5 This study
C-7 18 M 94 29 24 41 25 This study
C-8 21 M 92 16 14 17 14 This study
D-1 65 F 96 37 32 39 34 This study
D-2 42 M 96 21 19 20 19 This study
Donor 1 48 F 85 14 8 32 10 Ogasawara et al.,
2005
Donor 2 44 M 92 16 11 32 11 Ogasawara et al.,
2005
Donor 3 36 M 93 12 6 34 11 Ogasawara et al.,
2005
Donor 4 55 M 93 14 8 41 23 Ogasawara et al., 2005
Donor 5 35 M 93 13 10 34 11 Ogasawara et al., 2005
Donor 6 35 M 95 15 10 40 10 Yao et al., 2007d
Donor 7 32 M 93 40 35 53 35 Yao et al., 2007d
Donor 8 25 M 93 38 35 56 35 Yao et al., 2007d
Donor 9 57 M 93 31 28 38 35 Yao et al., 2007b,
2007d
Donor 10 39 M 94 17 12 43 12 Yao et al., 2007b,
2007d
QUIDC-3-14-5 65 F 91 39 34 48 39 Yao et al., 2007b
HERJC-2-16-5 48 F 93 40 31 73 31 Yao et al., 2007b
CABO-2-5-98 34 M 91 32 27 57 27 Yao et al., 2007b
CABO-1-31-6 42 M 94 43 37 64 37 Yao et al., 2007b
KIRGC-12-10-2 53 F 94 43 41 43 41 Yao et al., 2007b
KIRGC-2-2-6 57 F 96 39 38 39 39 Yao et al., 2007b
CB-1 0 – 93 6 4 7 4 This study
(continued on next page)
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Table 1 (continued)
Sample Age Sex No.
of
cells
No. of
haplotypes
No. of nonaggregate
haplotypes by
nucleotide
substitutions
No. of cells
with
nonaggregate
sequences
No. of cells with
nonaggregate
sequences defined
by substitution
Reference
CB-2 0 – 187 30 23 85 29 This study
CB-3 0 – 95 18 15 49 16 This study
Total – – 5071 1693 1408 2753 1496 –
Note — Donors 9 and 10 that were reported in Yao et al. (2007d) refer to BURRC-9-23-4 and GREHC-2-10-5 in Yao et al. (2007b), respectively.
We counted the number of haplotypes (including the aggregate mtDNA haplotype [which has the highest frequency in a population of cells and
bears the consensus sequence; Table S3] and nonaggregate haplotypes that differed from the aggregate sequence by nucleotide substitutions
or indels [insertions and deletions] or both) and the number of nonaggregate haplotypes that differed from the aggregate type only by
nucleotide substitutions, based on the mutations detected in a population of single CD34+ cells from each donor (Table S4). As the
nonaggregate haplotypemay be shared by several single cells, which reflects the clonal expansion of the clone, we then counted the number of
cells harboring the nonaggregate haplotypes or nonaggregate haplotypes by nucleotide substitutions for each donor.
364 Y.-G. Yao et al.0.16 as compared to conventional Taq DNA polymerase;
Takara Bio. Inc.), 0.5 μM of each forward and reverse outer
primer (L15594: 5′-CGCCTACACAATTCTCCGATC-3′ and H901:
5′-ACTTGGGTTAATCGTGTGACC-3′), and 5 μL of cell lysates.
PCR amplification was run on the GeneAmp PCR system
9700 (Applied Biosystems, Foster City, CA) with the
following thermal conditions: one denaturation cycle of
94 °C for 3 min; 35 amplification cycles of 94 °C for 30 s,
52 °C for 40 s and 72 °C for 1 min with a 5-second increase
per cycle; and a full extension cycle of 72 °C for 10 min.
The second PCR was performed in 50 μL of reaction
mixture containing 400 μM of each dNTP, 2 units of TaKaRa
LA Taq™, 0.5 μM of each forward and reverse inner prim-
ers (L15990: 5′-TTAACTCCACCATTAGCACC-3′ and H650:
5′-GAAAGGCTAGGACCAAACCTA-3′), and 5 μL of first PCR
product under the same amplification conditions as the
first PCR but with an extension time of 90 s at 72 °C per cycle.
Second PCR products were purified and then sequenced by
using the BigDye Terminator v3.1 Cycle Sequencing Kit on the
3100 DNA Sequencer (Applied Biosystems). The same sequenc-
ing primers described previously (Yao et al., 2007b, 2007d)
were used to determine the entire mtDNA control region
sequence.
Identification of mtDNA sequence variation and
statistical analysis
Germline sequence variants in the consensus/aggregate
sequences of single CD34+ cells from each subject were scored
relative to the revised Cambridge Reference Sequence (rCRS)
(Andrews et al., 1999). Sequencing electrophoregram of each
single cell was proof-read, as reported previously (Yao et al.,
2007b, 2007d), and mutation was scored by referring to the
aggregate sequence of the donor. Cells with contamination
were recognized using the same strategy as described in our
previous study (Yao et al., 2007a). In brief, if the mtDNA
sequence of a single cell from a particular subject did not
contain or had heteroplasmy at all of the variants detected in
the aggregate sequence for that subject, it was regarded as
being contaminated. The overall contamination rate was very
low (around 0.4% of total single cells) in this study and
exclusion of these contaminated cells did not influence the
result. We scored for heteroplasmy (co-existence of wild-typeand mutant alleles) of certain mtDNA variants, based on the
electrophoregram in which mutant alleles were present at
N10% of the highest peak. As nearly all identified mtDNA
mutations were heteroplasmic in cells (with a mutant ratio
varying from N10% to 100%; Fig. S2), we counted the mutation
regardless of its exact level of heteroplasmy. Length variation
of the poly C-tract in region 303–309 was scored by direct
counting of the base shift of T at nucleotide 310. A length
mutation of the AC repeat in region 515–524 in the third
hypervariable segment was also scored on the basis of the
sequencing electrophoregram. But, a length variation of the
poly C-tract in region 16184–16193, caused by variant
16189 TNC, was not considered in this study because most of
them were heteroplasmic of multiple poly C-tracts (N10 Cs)
and could not be conservatively counted according to
sequencing chromatographs.
As the majority of single cells from each donor shared the
same consensus mtDNA sequence (which we defined as the
aggregate haplotype), we define a cell with a unique haplotype
if this cell differed from the aggregate haplotype by containing
extra nucleotide alteration(s). We used the number of
haplotypes in a population of 100 cells from each sample as
an index to compare frequencies of mtDNA sequence variation
among different samples. This index reflects the total number
of mutations that occurred or retained within a given number
of cells and not the frequency of the cell clone harboring
certain mutation(s) (Yao et al., 2007b, 2007d). As polynucle-
otide length mutations have different mutation mechanisms
compared to nucleotide substitutions, we mainly focused on
analysis of nucleotide substitutions, as represented by the
number of haplotypes defined by nucleotide substitutions per
100 cells in our analysis. An aging effect on an mtDNA variation
level in a cell population was evaluated by the linear regression
analysis using the GraphPad Prism 4.0.Results
Data quality control
Single cell analysis has a very high sensitivity to detect
mtDNA mutations present at low levels. However, this
technique also poses challenges, especially to eliminate
Family A
A-1
A-2 A-3
A-4 A-5 A-6
female male
Family C
C-1 C-2 C-3
C-4 C-5 C-6
C-7 C-8
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B-1 B-2 B-3 B-4 
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Figure 1 Pedigrees of the four families analyzed in this study. Members of four families (A, B, C, and D) were recruited for
examination of mtDNA control region sequence in single CD34+ cells. Individuals who provided blood samples are marked in gray; ages
are listed in Table 1.
365mtDNA variation in CD34+ cells from familyartifacts caused by multiple-step PCR and contamination
(Reeve et al., 2009; Yao et al., 2007a). We benefited from
our previous experience of single cell analysis (Ogasawara et
al., 2005; Yao et al., 2007b, 2007d), and we believe that our
strategy was sufficiently stringent to maintain data reliabil-
ity. First, we used the same high fidelity TaKaRa LA Taq™
DNA polymerase for PCR and negative controls during the
amplification. Application of the same reagents for all
samples should yield similar levels of background sequence
variation inevitably arising from PCR amplification, and
should not affect the overall pattern of mutation rate.
Second, we were able to consistently reproduce the majority
of mutations (~80%) in single cells among duplicates in
independent amplifications of single cells from donors D-2
and B-11. Moreover, the levels of mtDNA mutation in each
single cell population of the duplicates from the same donor
were similar. Finally, we employed the same phylogenetic
approach as described for single cell analysis (Yao et al.,
2007a) in order to identify and eliminate potential cases of
contamination.Aging effect on the accumulation of mtDNA
variations in single CD34+ cells
A total of 5071 single CD34+ cells sorted from 51 PB samples
collected from 49 healthy donors with age ranging from 0 to
89 years were (re-)analyzed in this study (Table 1). Among
them, 32 individuals were from four families (6 from FamilyA, 16 from Family B, 8 from Family C, and 2 from Family D).
Pedigrees of the families and selected family members are
illustrated in Fig. 1. The other 17 individuals were as follows:
14 healthy individuals (two donors were sampled twice at
different time points Yao et al., 2007b) reported in our
previous studies (Yao et al., 2007b, 2007d); three CB
samples also were included due to the paucity of young
individuals in our families (only one donorb18 years old;
Table 1). When variation levels of the mtDNA control region
(the number of haplotypes defined by nucleotide substitu-
tions per 100 cells) were plotted against ages of individual
donors, we observed a roughly age-related accumulation
pattern of mtDNA sequence variations in single CD34+ cells,
although the correlation was moderate (r2 =0.19, P=0.001;
Table 1, Fig. 2A and Table S1). We also performed the
analysis using just the adult samples, to exclude potential
bias of three CB samples and one young donor (age 13), a
similar result was observed (r2 =0.17, P=0.004; Table S1). As
different families had different number of donors, we
included “Family” as a control variable, but the result was
not changed (r=0.40, P=0.004; Table S1). We obtained same
results when we considered the number of total haplotypes
(defined by nucleotide substitutions and insertions/deletions)
per 100 single cells (Table S2). Overall, a high frequency of
mtDNA mutation was not always present in CD34+ cells from
donors older than 75 years, as compared to donors younger
than 75 years old or even much younger donors less than
30 years old. This pattern may reflect the heterogeneity
within and the dynamics of CD34+ cell proliferation in vivo,
366 Y.-G. Yao et al.and we cannot exclude a bias due to sampling of compara-
tively few younger donors. The high level of mtDNA variation
in CD34+ cells from CB or donors with young age seemed to
suggest that there is not necessarily a low mutation rate at
young age andmtDNAmutations accrue in CD34+ cells not only
after birth.Family-specific pattern for age-dependent
accumulation of mtDNA variations in single
CD34+ cells
Our previous work demonstrated that the level of mtDNA
sequence heterogeneity in murine HSCs and progenitors was
modulated by the nuclear genetic background (Yao et al.,
2007c), and we speculated that this might also be observ-
able in human. Although the best samples to address this
hypothesis should be monozygotes, maternally related mem-
bers from the same family may be helpful. Plots of mtDNA
mutation levels against ages in the families with at least 5
members displayed remarkably difference between families:
there was a significant correlation between the age and the
mtDNAmutation level in Family A (r2=0.79; P=0.018; Figs. 2B
and S1), whereas the mutation levels in the 16 donors in
Family B (r2=0.04; P=0.485) showed no clear tendency forN
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Figure 2 Number of mtDNA control region haplotypes in a popula
number of haplotypes (characterized by nucleotide substitutions)/
family members. (A) All 51 samples were derived from 49 healthy do
twice at different time points (Yao et al., 2007b). Among them, 32 ind
16 from Family B, 8 from Family C, and 2 from Family D). The other
(Ogasawara et al., 2005; Yao et al., 2007b, 2007d) and three cord bloo
shown relative to the donors' age: (B) 6 members of Family A, (C) 16 m
Family C.age-dependent accumulation of mtDNA mutations in single
CD34+ cells, mainly because younger donors had surprisingly
high levels of mtDNA mutations (Fig. 2C). In four maternally
related members in Family C, an age-related pattern was
evident but not statistically significant (r2=0.76; P=0.128)
(Fig. 2D). The results indicated that the accumulation ofmtDNA
mutations in single CD34+ cells was indeed influenced by the
family genetic backgrounds of families, as the accumulation
rate differed in various pedigrees. Note that our observation for
families A and C was based on limited number of donors, and
larger cohorts will be necessary to further validate our result.
Family-specific variants or recurrent mutations in
single CD34+ cells?
The age-related accumulation of specific variants, such as
C150T, A189G, T408A, and T414G, has been reported in
leukocytes, muscle tissues, and fibroblasts (Michikawa et al.,
1999; Wang et al., 2001; Zhang et al., 2003). Some of these
variants are highly hypervariable (e.g. C150T and A189G),
according to the estimation of the available worldwide
populations (Soares et al., 2009; Stoneking, 2000), but other
sites appear to be less mutable and may be tissue or cell-
specific. In our previous experiments aimed to trace donor
CD34+ clones in a recipient after transplantation, we foundB) Family A
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tion of CD34+ cells. Haplotype frequencies were defined by the
100 single CD34+ cells from unrelated healthy individuals and
nors in the age range of 0–89, in which two donors were sampled
ividuals were newly recruited from four families (6 from family A,
17 individuals consisted of previously reported 14 healthy donors
d donors (this study). The number of haplotypes in each donor was
embers of Family B, and (D) 4 members (C-1, C-4, C-7 and C-8) of
367mtDNA variation in CD34+ cells from familythat a small portion of CD34+ cells from the sibling samples
shared certain mtDNA variants, suggesting potential family-
specific variants if not recurrentmutations (Yao et al., 2007b).
To further examine this pattern for a potentially high
prevalence of somatic mutations in CD34+ cells, we first
compiled the mtDNA control region mutation spectrum of
1952 CD34+ cells from 20 PB samples collected from 18
unrelated individuals (Table 1 and Fig. 3A): 16 samples from
14 healthy donors reported previously (Ogasawara et al.,
2005; Yao et al., 2007b, 2007d); three CB samples; one sample
from a member (C-2) of Family C. The mutation pattern from
these 18 unrelated individuals was then compared with those
from four different families (A, B, C, and D). An occurrence of
each variant (in heteroplasmic or homoplasmic status) was
scored according to its presence in a donor, but the variant
frequency in a cell population from the donor was neglected.
The top five highly mutational sites were 146, 16129, 204,
16311, and 16131 in these 18 unrelated individuals (Figs. 3A
and S2). Except for 16131, the positions were all listed as
hypervariable sites in the mutational hotspot list compiled by
Soares et al. (2009) on the basis of 2196 complete mtDNA
genomes from worldwide populations (Fig. 3B). We also
identified several variable sites, such as 42, 64, 16038, and
16086, which had a modest or low rate in the worldwide
human mtDNA population data, but they had a relatively high
frequency in the data from the 18 unrelated individuals
(Fig. 3A). Further studies are required to address why these
variants are so highly prevalent in CD34+ cells.
Figs. 3C and 3D represent the highest mutational hits in the
maternally related members from Families A and B, respec-
tively. In Family A, a total of 15 sites hadmutation hits at least
twice, among which 16192 and 204 were most frequent, and
the other 12 sites showed a similar mutational frequency.
Family B displayed a total of 16 sites with mutation hits at
least four times, among which 146, 204, 16129, and 16131
were the top four, followed by sites 16093, 16150, and 16187.
Of interest, the top four sites (146, 204, 16129, and 16131) in
Family B matched four of the top five hypervariable sites (146,
16129, 204, 16311, and 16131) present in the 18 unrelated
individuals (Fig. 3A). In particular, the occurrence of variation
at site 16131 ranked fourth in both Family B and the 18
unrelated individuals, suggesting that this variant might be
more prone to undergo somatic change in single CD34+ cells.
We also observed a relatively high frequency of apparently
family-unique variation at sites 16192, 16079, 215 and 217 in
members from Family A (Figs. 3C and S1) and at sites 16150,
16187 and other sites in members from Family B (Fig. 3D).
These mutations were present at either low frequency or
were absent in 1952 single CD34+ cells from the 18 unrelated
individuals and in the complete mtDNA database from
worldwide populations. Although the frequency of a certain
variant may be biased, due to the limited number of donors in
each family, we inferred unique mutation distribution
patterns in single CD34+ cells from different families.Discussion
There is accumulating evidence that mtDNA mutations play
important roles in human disease and in physiologic aging
(Taylor and Turnbull, 2005; Wallace et al., 2010) and mtDNA
mutations are common in normal and tumor tissues (Greavesand Turnbull, 2009; He et al., 2010; Yao et al., 2007d). The
aging of hematopoietic stem cells (HSCs) is complex and
multifactorial (Sahin and Depinho, 2010), accompanying with
age-dependent accumulation of mtDNAmutations (Shin et al.,
2004). However, whether accumulated mtDNA mutations in
HSCs and progenitors affect their developmental or function,
has not been sufficiently resolved (Sahin and Depinho, 2010;
Shin et al., 2004; Yao et al., 2007c). Recently, Norddahl et al.
(2011) demonstrated that hematopoietic defects in mice
carrying a proofreading-defective mtDNA polymerase is remi-
niscent of premature HSC aging. They further showed that
rapid accumulation of mtDNA mutations had little functional
effect on the HSC pool, but would cause distinct differentiation
blocks for downstream progenitor cells (Norddahl et al., 2011).
In the current work, there was a tendency for age-
associated mutation accumulation in human CD34+ cells,
but the mutation levels in certain young donors were not
necessarily low (Fig. 2 and Table 1), suggesting that CD34+
cells accumulated mutations at all stages of growth. Further-
more, age-related mutation accumulation seemed to be
affected by family genetic background, varying substantially
from one family to another. Of note, various mutational
hotspots in the maternally related individuals (Family A or B)
were also observed as hypervariable mutations in single cell
populations from the 18 unrelated individuals and in 2196
complete mtDNAs from the worldwide populations (Soares et
al., 2009). Therefore, it seems probable that highly fre-
quent variants/mutations in single CD34+ cells do not occur
randomly. Forster et al. (2002) analyzed the mtDNAmutations
in 248 pedigrees living in the high-radiation peninsular and in
nearby low-radiation islands in Kerala, India, to characterize
radiation-associated mtDNA mutations; they surmised that
radioactive conditions significantly accelerated mtDNA muta-
tions in evolutionarily hot spots between mothers and their
offspring. Our current study of mutational hotspots in single
CD34+ cells is consistent with their observation.
In Drosophila, mtDNA haplotypes' influence on the longev-
ity has varied on different nuclear backgrounds, suggesting
the mtDNA effects could be masked or exaggerated by
significant interactions with the nuclear allelic variation
(Rand et al., 2006). In humans, there also appeared to be an
effect of inheritedmtDNA variants on longevity, dependent on
the population, probably due to different nuclear genetic
background (Alexe et al., 2007; Dato et al., 2004; Santoro et
al., 2006). Therefore, aging and longevitymay be regulated by
nuclear gene variants associated with inherited and somatic
mtDNA variations/mutations in nuclear-mitochondrial inter-
action (Santoro et al., 2006; Vendelbo and Nair, 2011). As
more than 98% of the mitochondria's proteins are encoded by
nuclear genes, and coordinated expression of nuclear and
mitochondrial genes is indispensable for mitochondrial func-
tion (Calvo and Mootha, 2010), it is highly plausible that
nuclear-mitochondrial epistatic interactions in different fam-
ilies account for the diverse pattern of mtDNA mutation
accumulation in single CD34+ cells. The lack of aging-related
accumulation of mtDNA mutation in Family B, but not in
families A and C, was simply caused by an elevated level of
mtDNAmutation in donors at young age (Fig. 2). Does Family B
harbor a “mutagenic background” that accounts for their high
load ofmutations? Apparently, we have no clear answer to this
question based on the current observation. As CD34+ cells
are very heterogeneous and replenish during hematopoiesis
C) Family A (N=6)
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Figure 3 Mutational hot spots of the mtDNA control region in single CD34+ cells and in reported complete mtDNAs from worldwide
populations. Mutational hot spots were scored, according to their occurrences in the respective individual, but with disregarding their
frequencies in a cell population from the individual. As the number of donors in each family varied, we arbitrarily regarded a certain
site as a mutational hot spot if mutations hit the site at least in 3 donors in 18 unrelated healthy individuals (A), 2 donors in Family A
(N=6) (C), and 4 donors in Family B (N=16) (D). The 18 unrelated healthy individuals included one member (C-2) of Family C in
addition to 17 unrelated donors (14 reported healthy individuals (Ogasawara et al., 2005; Yao et al., 2007b, 2007d) and three cord
blood donors). The mutational hot spots in worldwide mtDNAs are listed (B) when mutations appear at least 30 times in the global tree
of 2196 complete mtDNA sequences (Soares et al., 2009).
368 Y.-G. Yao et al.(Doulatov et al., 2012), it is possible that mutation level will
finally reach a platform due to the balance of accumulation
and differentiation/disappearance of mutated cells in those
donors with a “mutagenic background”, irrespective of age.
Considering the results of functional assays of HSCs and
progenitors with mtDNA mutations (Yao et al., 2007c), we
would expect no tight connection between mutation
frequency and functional consequence in the mutated CD34+
cells, or in the hematopoietic systems of these young in-
dividuals with a high level of mtDNA mutation.
In this study, besides the high hits for the evolutionarily
hypervariable sites, we also noticed that certain mtDNA
variants were shared by family members, pedigree-specific
occurrence of mtDNA variants. This observation was unex-
pected but confirmed our previous speculation for a family-
specific occurrence of mtDNA variants among siblings (Yao et
al., 2007b). We hypothesized that this variation was shaped
by family genetic background. Indeed, others have recently
shown that somatic point mutations in the mtDNA control
region are influenced by genetic background and associated
with healthy aging (Rose et al., 2010). How this seemingly
family-specific mtDNA mutation occurs and accumulates
and whether it is restricted to CD34+ cells but not other
tissues are unknown. As the family differences for mutationaccumulation and presence of family-specific variants are
obvious in this study, one likely explanation for this
observation is the maternal inheritance of low-level variants
or maternal influence on occurrence of low-level variants.
Direct experimental data is needed to confirm this specula-
tion. Nonetheless, our observations contribute to an infer-
ence of complexity in the mechanism of mtDNA mutations in
single cells. The pedigree-specific mtDNA variants could
have potential forensic consequences and individual pat-
terns of mutations could help to identify individuals instead
of matri-lineages (Salas et al., 2007).
The mtDNA control region plays a crucial role in regulating
mtDNA replication and transcription (Falkenberg et al., 2007;
Shadel and Clayton, 1997). Deleterious mutations in this
region would be expected to have functional consequences (Bi
et al., 2010). We do not know the exact role of the mutations
that were frequently observed in the mtDNA control region
of CD34+ cells. As some of these highly mutated sites,
such as 146, 204 and 16129, are also hypervariable in the
general populations, indicating that they are unlikely to be
of deleterious significance. However, the accumulation of
these mutations is unlikely to be a simple byproduct of
oxidative damage, as we observed high frequencies of
various mutations at both evolutionarily hypervariable sites
369mtDNA variation in CD34+ cells from familyand seemingly family-specific sites. For instance, the
frequency of variant A215G is relatively high in pedigrees
from a high radiation area (Forster et al., 2002), but
this variant also was present in two out of six individuals in
Family A. The age-associated variant T414G (Michikawa et
al., 1999) was only found in two CD34+ cells from a 48-year
old healthy donor in our previous study (Yao et al., 2007b) and
in one 79-year old donor (C-2) in this study. Further work is
required to clarify putative functional effects of these variants
on mtDNA replication and mtDNA copy number within a cell
(Falkenberg et al., 2007; Shadel and Clayton, 1997).
Our current study has some limitations. First, due to the
relatively low number of subjects per family and limited
number of families analyzed, the family-related patterns as
we observed here need to be further confirmed. Second, we
did not perform any functional characterizations for those
CD34+ cells with and without mtDNA mutations, to show the
potential effect of mtDNA variants. It remains unknown
whether there is a family-specific mutation accumulation in
mtDNA coding region in CD34+ cells. Further study should be
carried out to answer these questions.
In summary, we provide, to the best of our knowledge, the
mutation spectra of the human mtDNA control region in CD34+
hematopoietic cells from a large cohort of maternally related
and unrelated individuals. The results in general support
age-related accumulation of mtDNA mutations, but further
discerned a family-specific rate of mtDNA mutation accumu-
lation and mutational sites. The exact biological significance
of accumulation of aging-related and family-specific mtDNA
mutations in CD34+ cells awaits future study.Acknowledgments
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